24 June 2016

Consortium on Stage at GHIT Annual Partners Meeting

On June 7, 2016, the GHIT Fund held its third Annual Partners Meeting to discuss the impact of the fund on the ground. The GHIT-funded PEDPZQ Consortium was invited to present its progress in clinical trials in African countries. 

Dr. Kojima from Astellas (Japan) represented the Consortium, and introduced its mission, vision and progress of activities; Dr. Mahende, from the Ifakara Health Institute (Tanzania) and principal investigator of the PEDPZQ taste study, joined the presentation. The PEDPZQ Consortium was acknowledged by the audience as a success model of global partnership on public health issues.

Click here for the event report by the GHIT fund.

The PEDPZQ Consortium presented at the GHIT Annual Partners Meeting 2016

The orally dispersible tablets (left) were showcased next to the currently available 600 mg commercial tablet (right).